AtlasClear Holdings, Inc. |
Director |
Common Stock |
243K |
$1.13M |
$4.64 |
Feb 9, 2024 |
Direct |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
904M |
$1.08M |
$0.00 |
Nov 14, 2024 |
Direct |
Akari Therapeutics Plc |
Director |
American Depositary Shares representing Ordinary Shares |
452K |
$506K |
$1.12 |
Mar 20, 2025 |
Direct |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
40.4M |
$48.5K |
$0.00 |
Nov 14, 2024 |
By Davis Island Ventures LLC |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
39.8M |
$47.7K |
$0.00 |
Nov 14, 2024 |
By Quest Bio LLC |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
27.8M |
$33.4K |
$0.00 |
Nov 14, 2024 |
By Innovative Lifesci Investments LLC |
Akari Therapeutics Plc |
Director |
American Depositary Shares representing Ordinary Shares |
20.2K |
$22.6K |
$1.12 |
Mar 20, 2025 |
Davis Island Ventures LLC |
Akari Therapeutics Plc |
Director |
American Depositary Shares representing Ordinary Shares |
19.9K |
$22.3K |
$1.12 |
Mar 20, 2025 |
Quest Bio LLC |
Akari Therapeutics Plc |
Director |
American Depositary Shares representing Ordinary Shares |
13.9K |
$15.6K |
$1.12 |
Mar 20, 2025 |
Innovative Lifesci Investment LLC |
Akari Therapeutics Plc |
Director |
Ordinary Shares, par value $0.0001 per share |
12.5M |
$15K |
$0.00 |
Nov 14, 2024 |
By TT Insurance Investment LLC |
Akari Therapeutics Plc |
Director |
American Depositary Shares representing Ordinary Shares |
6.25K |
$7K |
$1.12 |
Mar 20, 2025 |
TT Insurance Investment LLC |
Peak Bio, Inc. |
Director |
Common Stock |
0 |
$0 |
$0.27 |
Nov 14, 2024 |
Direct |
Peak Bio, Inc. |
Director |
Common Stock |
0 |
$0 |
$0.27 |
Nov 14, 2024 |
Indirect |
Monterey Innovation Acquisition Corp |
Director, 10%+ Owner |
Common Stock |
1.42M |
|
|
Mar 9, 2023 |
Indirect |
AtlasClear Holdings, Inc. |
Director |
Warrants |
354K |
|
|
Mar 20, 2024 |
Direct |
Akari Therapeutics Plc |
Director |
Stock Option (Right to Buy) |
225K |
|
|
Mar 20, 2025 |
Direct |
Monterey Innovation Acquisition Corp |
Director, 10%+ Owner |
Common Stock |
35K |
|
|
Mar 9, 2023 |
Direct |
Peak Bio, Inc. |
Director |
Convertible Notes |
0 |
|
|
Nov 14, 2024 |
Direct |
Peak Bio, Inc. |
Director |
Stock Option (Right to Buy) |
0 |
|
|
Nov 14, 2024 |
Direct |
Quantum FinTech Acquisition Corp |
Director |
Common Stock |
0 |
|
|
Feb 9, 2024 |
Direct |